Trial
NCT01758458
Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Merkel Cell Carcinoma
Intervention
Aldesleukin
Why stopped
A Phase I/II study (NCT01758458) is now recruiting
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-19